Bryan W. Lepore

791 citations
9 papers · 641 indexed · h-index 8
Topics
Bacterial Genetics and Biotechnology (4 papers)Amino Acid Enzymes and Metabolism (3 papers)Antibiotic Resistance in Bacteria (3 papers)

In The Last Decade

Bryan W. Lepore

9 papers receiving 634 citations

Peers

Bryan W. Lepore
Comparison fields: 5 of 72
  • Molecular Biology 403
  • Genetics 162
  • Molecular Medicine 100
  • Renewable Energy, Sustainability and the Environment 100
  • Rheumatology 91
Replace Sharon D. Cosloy with:
Sharon D. Cosloy United States
Y. Yasutake Japan
Alexandra Vergnes France
L Langman Australia
Marta C. Justino Portugal
Ariane Proteau Canada
Lluis Masip Spain
W. T. Drabble United Kingdom
Michèle Lepelletier France
Chang‐Yub Kim United States
Bryan W. Lepore relative to Sharon D. Cosloy United States Sharon D. Cosloy's profile →
Citations per field
00.5×7.6×
Sharon D. Cosloy · 1×
Citations per year

Countries citing papers authored by Bryan W. Lepore

Since Specialization
Citations

This map shows the geographic impact of Bryan W. Lepore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan W. Lepore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan W. Lepore more than expected).

Fields of papers citing papers by Bryan W. Lepore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan W. Lepore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan W. Lepore. The network helps show where Bryan W. Lepore may publish in the future.

Co-authorship network of co-authors of Bryan W. Lepore

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan W. Lepore. A scholar is included among the top collaborators of Bryan W. Lepore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan W. Lepore. Bryan W. Lepore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 100
2 55
3 11
4 115
5 13
6 6
7 128
8 102
9 111

About Bryan W. Lepore

Bryan W. Lepore is a scholar working on Molecular Medicine, Biochemistry and Clinical Biochemistry, having authored 9 papers that have together received 641 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Molecular Medicine (100 citations), Biochemistry (91 citations) and Endocrinology (45 citations). Bryan W. Lepore has collaborated with scholars based in United States, Poland and Belarus. Frequent co-authors include Dagmar Ringe, Bert van den Berg, Mridhu Indic, Perry A. Frey, Frank J. Ruzicka, Dimki R. Patel, E.M. Hearn, Sunil Ojha, Shinichi Taoka and Ömer Kabil. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026